Danish pharmaceutical giant Novo Nordisk has confirmed a cyberattack in which threat actors gained unauthorized access to internal IT systems, exfiltrating pseudonymized patient data from clinical trials and, according to the alleged attackers, a trove of proprietary AI model assets. Novo Nordisk disclosed the incident on June 11, 2026, stating...
Læs hele artiklen hos kilden.
Kommentarer (0)
Ingen kommentarer ennå. Bli den første til å kommentere!